Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Zeidler

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Cancer Immunology, Immunotherapy : CII|February 8, 2011
Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XIIChristina Battke, Elisabeth Kremmer, Josef Mysliwietz, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2014
The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancerPatrick Weller, Agnes Bankfalvi, Xiang Gu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 20, 2002
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitorStephan Lang, Lina Lauffer, Christoph Clausen, et al.
Journal of Virology|March 30, 2004
Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBVMartin Schlee, Tanja Krug, Olivier Gires, et al.
Cancer Medicine|March 31, 2018
Tumor-derived extracellular vesicles activate primary monocytesKathrin Gärtner, Christina Battke, Judith Dünzkofer, et al.
Journal of Molecular Biology|November 5, 2019
Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 ComplexVincenzo Alterio, Markus Kellner, Davide Esposito, et al.
Cells|January 11, 2024
Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized MiceSebastian J Theobald, Elena Fiestas, Andreas Schneider, et al.
Cancer Immunology, Immunotherapy : CII|March 28, 2007
Immune restoration in head and neck cancer patients after in vivo COX-2 inhibitionStephan Lang, Sanjay Tiwari, Michaela Andratschke, et al.
Experimental Hematology & Oncology|March 20, 2025
All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasoneTheresa Kaeuferle, Maximilian Zwermann, Nadine Stoll, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 17, 2015
Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activityNarasimha Rao Uda, Volker Seibert, Frank Stenner-Liewen, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Cancer Immunology, Immunotherapy : CII|February 8, 2011
Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XIIChristina Battke, Elisabeth Kremmer, Josef Mysliwietz, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2014
The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancerPatrick Weller, Agnes Bankfalvi, Xiang Gu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 20, 2002
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitorStephan Lang, Lina Lauffer, Christoph Clausen, et al.
Journal of Virology|March 30, 2004
Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBVMartin Schlee, Tanja Krug, Olivier Gires, et al.
Cancer Medicine|March 31, 2018
Tumor-derived extracellular vesicles activate primary monocytesKathrin Gärtner, Christina Battke, Judith Dünzkofer, et al.
Journal of Molecular Biology|November 5, 2019
Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 ComplexVincenzo Alterio, Markus Kellner, Davide Esposito, et al.
Cells|January 11, 2024
Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized MiceSebastian J Theobald, Elena Fiestas, Andreas Schneider, et al.
Cancer Immunology, Immunotherapy : CII|March 28, 2007
Immune restoration in head and neck cancer patients after in vivo COX-2 inhibitionStephan Lang, Sanjay Tiwari, Michaela Andratschke, et al.
Experimental Hematology & Oncology|March 20, 2025
All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasoneTheresa Kaeuferle, Maximilian Zwermann, Nadine Stoll, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 17, 2015
Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activityNarasimha Rao Uda, Volker Seibert, Frank Stenner-Liewen, et al.
Pageof 7